Skip to content
TrialScanner

NCT04656301

Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder

Phase 2CompletedCMPSCollaborator

Registry record

Lead sponsor
New York State Psychiatric Institute
Conditions
Body Dysmorphic Disorders
Primary completion
Nov 2, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04656301 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04656301: Safety and Efficacy of... | TrialScanner